Видео ютуба по тегу Omaha Hematologists

UNMC's Oncology and Hematology Fellowship Program
UNMC's Oncology and Hematology Fellowship Program
Meet Omaha Oncologist Dr. Laxmi Narayana Buddharaju (Dr. Budd) of Oncology Associates
Meet Omaha Oncologist Dr. Laxmi Narayana Buddharaju (Dr. Budd) of Oncology Associates
Dr. Jairam Krishnamurthy, Hematology, Oncology
Dr. Jairam Krishnamurthy, Hematology, Oncology
Meet Dr. Losole
Meet Dr. Losole
Dr. Marcel Devetten, Hematology
Dr. Marcel Devetten, Hematology
From Omaha to Global Health: Dr. Xu's Path in Hematology
From Omaha to Global Health: Dr. Xu's Path in Hematology
UNMC Hematology and Oncology Fellowship Program
UNMC Hematology and Oncology Fellowship Program
Dr. Taylor Losole - Boys Town National Research Hospital
Dr. Taylor Losole - Boys Town National Research Hospital
Surviving Lymphoma - Jeff's Story - Nebraska Medicine
Surviving Lymphoma - Jeff's Story - Nebraska Medicine
Nebraska Cancer Treatment Will Travel
Nebraska Cancer Treatment Will Travel
Minnie Abromowitch, M.D.—Children's Hospital & Medical Center, Hematology-Oncology
Minnie Abromowitch, M.D.—Children's Hospital & Medical Center, Hematology-Oncology
Julie Vose, MD, on management of common toxicities with CAR-T therapies
Julie Vose, MD, on management of common toxicities with CAR-T therapies
Julie Vose, MD, discusses whether polatuzumab improves outcomes in DLBCL patients
Julie Vose, MD, discusses whether polatuzumab improves outcomes in DLBCL patients
Nessie's Story - The Nebraska Medical Center
Nessie's Story - The Nebraska Medical Center
First Day of Hematology
First Day of Hematology
Beating Lymphoma - Peg's Story - The Nebraska Medical Center
Beating Lymphoma - Peg's Story - The Nebraska Medical Center
Julie Vose, MD, on if CAR-T therapies are showing impressive results in lymphoma
Julie Vose, MD, on if CAR-T therapies are showing impressive results in lymphoma
Julie Vose, MD, tells us about results of the AUGMENT study in relapsed/refractory indolent NHL
Julie Vose, MD, tells us about results of the AUGMENT study in relapsed/refractory indolent NHL
Blood Cancers - Nebraska Medicine
Blood Cancers - Nebraska Medicine
Julie Vose, MD, discusses improvements made in the delivery of CAR-T therapies in lymphoma
Julie Vose, MD, discusses improvements made in the delivery of CAR-T therapies in lymphoma